Lung damage in rheumatoid arthritis: complex points of clinical practice

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The most severe systemic manifestations of rheumatoid arthritis (RA) include interstitial lung disease, which can become a symptomatic feature of the disease. With the development of pulmonary damage in RA patients, the range of differential diagnosis should include the point of toxic effects of methotrexate used for RA treatment, as well as infectious diseases, in particular tuberculosis. The presented case demonstrates the difficulties of pulmonary lesions’ differential diagnosis in RA patients.

Full Text

Restricted Access

About the authors

Maria F. Beketova

M.V. Lomonosov Moscow State University

Author for correspondence.
Email: beketova_maria@rambler.ru
ORCID iD: 0000-0001-5562-0969

resident physician at the department of internal medicine of the faculty of fundamental medicine

Russian Federation, 119234, Moscow, 1 Leninskiye Gory Str.

Olga A. Georginova

M.V. Lomonosov Moscow State University

Email: olga.georginova@gmail.com
ORCID iD: 0000-0002-7542-8189

phd in medical sciences, associate professor of the department of internal medicine of the faculty of fundamental medicine, rheumatologist, Medical Scientific and Educational Center 

Russian Federation, 119234, Moscow, 1 Leninskiye Gory Str.

Tatyana N. Krasnova

M.V. Lomonosov Moscow State University

Email: krasnovamgu@yandex.ru
ORCID iD: 0000-0001-6175-1076

phd in medical sciences, associate professor, head of the department of internal medicine of the faculty of fundamental medicine

Russian Federation, 119234, Moscow, 1 Leninskiye Gory Str.

References

  1. Насонов Е.Л., Ананьева Л.П., Авдеев С.Н. Интерстициальные заболевания легких при ревматоидном артрите: мультидисциплинарная проблема ревматологии и пульмонологии. Научно-практическая ревматология. 2022; 60(6): 517–534. [Nasonov E.L., Ananyeva L.P., Avdeev S.N. Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology. Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology. 2022; 60(6): 517–534 (In Russ.)]. https://dx.doi.org/10.47360/1995-4484-2022-1. EDN: SQJDEM.
  2. Fragoulis G.E., Nikiphorou E., Larsen J. et al. Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: Current concepts for the diagnosis and treatment. Front Med (Lausanne). 2019; 6: 238. https://dx.doi.org/10.3389/fmed.2019.00238.
  3. Distler O., Highland K.B., Gahlemann M. et al; SENSCIS Trial Investigators. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med. 2019; 380(26): 2518–28. https://dx.doi.org/10.1056/NEJMoa1903076.
  4. Lamb Y.N. Nintedanib: A review in fibrotic interstitial lung diseases. Drugs. 2021; 81(5): 575–86. https://dx.doi.org/10.1007/s40265-021-01487-0.
  5. Barakat A., Grover K., Peshin R. Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis. Springerplus. 2014: 3: 751. https://dx.doi.org/10.1186/2193-1801-3-751.
  6. Arakawa H., Yamasaki M., Kurihara Y. et al. Methotrexate-induced pulmonary injury: Serial CT findings. J Thorac Imaging. 2003; 18(4): 231–36. https://dx.doi.org/10.1097/00005382-200310000-00004.
  7. Rakesh K.Y., Raj K., Kachmar V. et al. Anti-cyclic citrullinated peptide antibodies in tuberculosis and human immunodeficiency virus. Int J Adv Med. 2020; 7(5): 804–8. https://dx.doi.org/10.18203/2349-3933.ijam20201615.
  8. Lima I., Oliveira R.C., Atta A. et al. Antibodies to citrullinated peptides in tuberculosis. Clin Rheumatol. 2013; 32(5): 685–87. https://dx.doi.org/10.1007/s10067-013-2173-y.
  9. Nyo M.T.L., Ally M.M.T.M., Van Duuren E.M., Arendse R. Poncet's disease in the preclinical phase of rheumatoid arthritis. Case Rep Rheumatol. 2018; 2018: 3571247. https://dx.doi.org/10.1155/2018/3571247.
  10. Higashiguchi M., Matsumoto T., Kitamura T. et al. Poncet's disease (reactive arthritis associated with tuberculosis). Intern Med. 2022; 61(21): 3245–49. https://dx.doi.org/10.2169/internalmedicine.9241-21.
  11. Sharma A., Pinto B., Dogra S. et al. A case series and review of Poncet's disease, and the utility of current diagnostic criteria. Int J Rheum Dis. 2016; 19(10): 1010–17. https://dx.doi.org/10.1111/1756-185X.12726.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Рис. Данные компьютерной томографии легких у пациентки Л. с ревматоидным артритом

Download (138KB)

Copyright (c) 2023 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies